Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CENTG1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA523356
Description
CENTG1 Polyclonal Antibody for Western Blot, ICC/IF, IHC (P)
The protein encoded by this gene belongs to the centaurin gamma-like family. It mediates anti-apoptotic effects of nerve growth factor by activating nuclear phosphoinositide 3-kinase. It is overexpressed in cancer cells, and promotes cancer cell invasion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.
Specifications
CENTG1 | |
Polyclonal | |
Unconjugated | |
Agap2 | |
AGAP2; AGAP-2; Arf GAP with GTP-binding protein-like, ANK repeat and PH domains 2; ArfGAP with GTPase domain, ankyrin repeat and PH domain 2; arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2; centaurin gamma1; centaurin, gamma 1; centaurin-gamma-1; CENTG1; cnt-g1; FLJ16430; GGAP2; GTP-binding and GTPase activating protein 2; GTP-binding and GTPase-activating protein 2; KIAA0167; mKIAA0167; nuclear GTPase PIKE; phosphatidylinositol 3-kinase enhancer; phosphatidylinositol-3-kinase enhancer; phosphoinositide 3-kinase enhancer; Pike | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
100050853, 116986, 216439, 481130, 65218 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.5 mg/mL | |
PBS with 0.05% BSA and 0.05% sodium azide | |
Q3UHD9, Q8CGU4, Q99490 | |
Agap2 | |
A portion of amino acids 450-500 of human AGAP2. | |
100 μg | |
Primary | |
Human, Mouse, Rat, Canine, Monkey, Horse | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction